Gsk (GSK) Return on Capital Employed [ROCE] (2009 - 2026)
Gsk (GSK) posted Return on Capital Employed [ROCE] of 14.81% for the quarter ended Sep 30, 2026, up 5.87 percentage points from 8.94% a year earlier but down 1.23 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk's Return on Capital Employed [ROCE] came in at 21.06%, up 10.27 percentage points from the prior year.
- Annual Return on Capital Employed [ROCE] shows a five-year change of +11.07 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Return on Capital Employed [ROCE] was 10.79% in the year ended Dec 31, 2024 (-7.06 pp), 17.85% in the year ended Dec 31, 2023 (+5.04 pp), 12.81% in the year ended Dec 31, 2022 (+4.95 pp) and 7.86% in the year ended Dec 31, 2021 (-2.13 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of 4.72% in the quarter ended Sep 30, 2024 to a high of 36.48% in the quarter ended Dec 31, 2025 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +5.98 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was the quarter ended Dec 31, 2025, with a gain of 26.05 percentage points; the weakest was the quarter ended Dec 31, 2024, with a drop of 7.09 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 16.04% (quarter ended Jun 30, 2026), 17.70% (quarter ended Mar 31, 2026) and 36.48% (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 43.74% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.33% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 11.32% |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 14.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.81% |
| Jun 30, 2026 | 16.04% |
| Mar 31, 2026 | 17.70% |
| Dec 31, 2025 | 36.48% |
| Sep 30, 2025 | 8.94% |
| Jun 30, 2025 | 6.14% |
| Mar 31, 2025 | 5.80% |
| Dec 31, 2024 | 10.44% |
| Sep 30, 2024 | 4.72% |
| Jun 30, 2024 | 7.19% |
| Mar 31, 2024 | 7.78% |
| Dec 31, 2023 | 17.52% |
| Sep 30, 2023 | 9.68% |
| Jun 30, 2023 | 8.66% |
| Mar 31, 2023 | 7.63% |
| Dec 31, 2022 | 18.93% |
| Sep 30, 2022 | 5.86% |
| Jun 30, 2022 | 5.41% |
| Mar 31, 2022 | 8.29% |
| Dec 31, 2021 | 8.10% |
API Access
Gsk Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();